Study participants needed

Every 72 seconds someone in America develops Alzheimer’s disease.

Alzheimer’s disease is a neurodegenerative disorder characterized by the progressive loss of memory and cognitive function, such as movement control and decision-making ability. Alzheimer’s disease is the most common cause of dementia in the elderly and affects about 18 million people worldwide – 5 million in the U.S. alone.

Physicians nationwide seek volunteers to participate in the ICARA study, a clinical study to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.

Physicians want men and women who:

·  Are between 50 and 89 years of age.

·  Have a diagnosis of mild to moderate Alzheimer’s disease.

·  Have a caregiver who is willing to be involved in the study with them.

Study participants will join more than 2,050 volunteers in 200 study sites across the U.S. and Canada. All study-related procedures and medication will be provided at no cost. During the study, each participant will be monitored by a medical team, including a physician.

To find out if a patient or loved one is eligible, visit the study Web site at www.ICARAstudy.com or call (888) 770-6366.

Trackback(0)

TrackBack URI for this entry

Comments (0)

Write comment